Nabih Maslah
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Scalable genotyping in fixed transcriptomes resolves clonal heterogeneity via single-cell sequencing.
Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026
Genetic screening of triple negative thrombocytosis patients identifies germline MPL compound mutations and SH2B3/LNK truncating mutations.
Journal: Haematologica
Published: March 06, 2026
Genetic screening of triple negative thrombocytosis patients identifies germline MPL compound mutations and SH2B3/LNK truncating mutations.
Journal: Haematologica
Published: March 06, 2026
JAK2V617F-dependent down regulation of SHP-1 expression participates in the selection of myeloproliferative neoplasm cells in the presence of TGF-β.
Journal: Journal of cellular and molecular medicine
Published: June 07, 2024
Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C.
Journal: British journal of haematology
Published: May 07, 2024
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.
Journal: Nature communications
Published: February 23, 2024
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells.
Journal: Leukemia
Published: November 13, 2023
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
Journal: American journal of hematology
Published: November 10, 2023
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM.
Journal: American journal of hematology
Published: September 29, 2023
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms.
Journal: Blood cancer journal
Published: June 29, 2023
Last Updated: 09/26/2026